Northwire Canada EditionFriday, July 10, 2026
Northwire
NNX 0.035 +0.0% ABX 51.85 −0.7% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.99 +10.5% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.40 −0.5% SGZ 0.045 +0.0% S 0.155 +29.2% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% NNX 0.035 +0.0% ABX 51.85 −0.7% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.99 +10.5% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.40 −0.5% SGZ 0.045 +0.0% S 0.155 +29.2% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0%
Production / Operations Routine +

Cannabix Expands BreathLogix Alcohol Screening Technology into Mining, Municipal and Aviation Sectors in Australia

Cannabix Expands Australian Footprint as MBT Certification Progresses Amidst Volatility

Executive Summary
  • Cannabix Technologies Inc. announced the deployment of its BreathLogix alcohol screening technology into mining, municipal, and aviation sectors in Australia on May 29, 2026.
  • Deployment is executed under an exclusive distribution partnership with Breathalyser Sales & Service Pty Ltd.
  • The automated system enables workplace safety compliance through pre-shift testing, identity verification, and integration into access control workflows without dedicated administration personnel.
  • Key features include contactless and straw modes, user photograph capture for identity verification, precise Blood Alcohol Content (BAC/BrAC) readings, and real-time SMS/email alerts to supervisors.
  • The system integrates with cloud-based BreathLogix Connect platform for secure data logging and reporting across multiple locations.
Material Impact
  • This news represents an execution update on the December 30, 2025 announcement regarding the first international distributor order with Breathalyser Sales & Service Pty Ltd.
  • The specific sector expansion (Mining, Municipal, Aviation) confirms commercial traction but does not disclose contract values or revenue figures.
  • Given the stock price decline from $0.75 on May 25 to $0.65 on May 28 prior to this release, the news serves as a stabilizing factor rather than a catalyst for significant upside without financial proof of scale.
  • The Marijuana Breath Test (MBT) certification milestones achieved in May 2026 (UL/CSA) complement this alcohol screening expansion, diversifying revenue streams but maintaining reliance on partnership execution.
  • No new capital raise or strategic investor entry is announced; dilution risk remains tied to previous financing structures.
BLO · Price
Company Overview
  • Company: Cannabix Technologies Inc., a technology company focused on breath-based detection solutions for alcohol and cannabis impairment.
  • Flagship Projects:
    • BreathLogix: Alcohol screening system targeting safety-critical industries (Mining, Maritime, Aviation). Features unmanned access control integration.
    • Marijuana Breath Test (MBT): Portable system detecting recent delta-9 THC use in breath within a 4-hour window using LC-MS analysis.
  • Development Status:
    • MBT has achieved UL/CSA certifications and FCC compliance. Peer-reviewed validation study published in Journal of Analytical Toxicology (March 2026).
    • BreathLogix has secured NHTSA approval for the Workplace Series device and USPTO patent grant for contactless breath analysis (October 2025).
Read the original news release →

More from Cannabix Technologies Inc.